Literature DB >> 1866375

Bioavailability of flurbiprofen following buccal administration.

D J Stalker1, S R Pollock.   

Abstract

The buccal absorption of flurbiprofen was evaluated in nine normal volunteers. Twenty milliliters of 2.5 mg/ml flurbiprofen solution (pH 8.03) was administered as a 1-min mouthwash or a 5-min mouthwash or swallowed. Serum was harvested from blood samples taken at specified times over a 12-hr period. Serum flurbiprofen concentration data indicate that the extent, but not the rate, of drug absorption was dependent upon the time of exposure of the flurbiprofen solution to the buccal membrane. Following the 1- and 5-min mouthwash treatments, 5.2 and 9.4% of the administered doses were absorbed, respectively.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1866375     DOI: 10.1023/a:1015852623136

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  10 in total

1.  Treating periodontal disease.

Authors:  M K Jeffcoat; R C Williams
Journal:  Dentistry       Date:  1986-04

2.  Flurbiprofen treatment of periodontal disease in beagles.

Authors:  M K Jeffcoat; R C Williams; W J Wechter; H G Johnson; M L Kaplan; J S Gandrup; P Goldhaber
Journal:  J Periodontal Res       Date:  1986-11       Impact factor: 4.419

3.  Buccal absorption of basic drugs and its application as an in vivo model of passive drug transfer through lipid membranes.

Authors:  A H Beckett; E J Triggs
Journal:  J Pharm Pharmacol       Date:  1967-12       Impact factor: 3.765

4.  Flurbiprofen treatment of human periodontitis: effect on alveolar bone height and metabolism.

Authors:  M K Jeffcoat; R C Williams; M S Reddy; R English; P Goldhaber
Journal:  J Periodontal Res       Date:  1988-11       Impact factor: 4.419

5.  A long-term study of flurbiprofen in rheumatological disorders: II. Osteoarthrosis.

Authors:  M Busson
Journal:  J Int Med Res       Date:  1986       Impact factor: 1.671

6.  A long-term study of flurbiprofen in rheumatological disorders: I. Rheumatoid arthritis.

Authors:  M Busson
Journal:  J Int Med Res       Date:  1986       Impact factor: 1.671

7.  A long-term study of flurbiprofen in rheumatological disorders: III. Other articular conditions.

Authors:  M Busson
Journal:  J Int Med Res       Date:  1986       Impact factor: 1.671

8.  Human buccal absorption of flurbiprofen.

Authors:  C L Barsuhn; L S Olanoff; D D Gleason; E L Adkins; N F Ho
Journal:  Clin Pharmacol Ther       Date:  1988-08       Impact factor: 6.875

9.  Determination of flurbiprofen in human serum by reverse-phase high-performance liquid chromatography with fluorescence detection.

Authors:  K S Albert; W R Gillespie; A Raabe; M Garry
Journal:  J Pharm Sci       Date:  1984-12       Impact factor: 3.534

10.  Flurbiprofen: a potent inhibitor of alveolar bone resorption in beagles.

Authors:  R C Williams; M K Jeffcoat; M L Kaplan; P Goldhaber; H G Johnson; W J Wechter
Journal:  Science       Date:  1985-02-08       Impact factor: 47.728

  10 in total
  1 in total

Review 1.  Clinical pharmacokinetics of flurbiprofen and its enantiomers.

Authors:  N M Davies
Journal:  Clin Pharmacokinet       Date:  1995-02       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.